PharmaCyte Biotech Sets 1-for-19 Reverse Stock Split for November 12

PUBT · 2d ago
PharmaCyte Biotech Sets 1-for-19 Reverse Stock Split for November 12
  • PharmaCyte Biotech will implement a 1-for-19 reverse stock split effective at 4:01 p.m. Eastern Time on November 12, 2026.
  • Split-adjusted trading on the Nasdaq Capital Market will begin November 13, 2026, under the existing ticker PMCB.
  • The consolidation aims to restore compliance with Nasdaq's minimum bid price requirement for continued listing.
  • Outstanding common shares will fall from approximately 10,755,649 as of November 11, 2026, to approximately 566,087; authorized shares will remain unchanged.
  • No fractional shares will be issued; holders will receive cash based on the split-adjusted November 12, 2026, closing price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PharmaCyte Biotech Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261111266912) on November 11, 2026, and is solely responsible for the information contained therein.